ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 124 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q2 2021. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $29,826 | -39.0% | 19,884 | -35.4% | 0.00% | – |
Q2 2023 | $48,905 | +116.4% | 30,758 | -2.4% | 0.00% | – |
Q1 2023 | $22,602 | +61.4% | 31,506 | +119.1% | 0.00% | – |
Q3 2022 | $14,000 | -33.3% | 14,377 | -16.9% | 0.00% | – |
Q2 2022 | $21,000 | +10.5% | 17,306 | +17.7% | 0.00% | – |
Q1 2022 | $19,000 | -83.6% | 14,702 | -77.8% | 0.00% | -100.0% |
Q4 2021 | $116,000 | -14.1% | 66,118 | +6.5% | 0.00% | -50.0% |
Q3 2021 | $135,000 | -53.4% | 62,089 | -25.2% | 0.00% | -33.3% |
Q2 2021 | $290,000 | +15.5% | 82,959 | +226.4% | 0.00% | 0.0% |
Q1 2021 | $251,000 | -82.2% | 25,420 | -81.4% | 0.00% | -85.7% |
Q3 2020 | $1,411,000 | +365.7% | 136,966 | +341.8% | 0.02% | +162.5% |
Q1 2020 | $303,000 | -31.3% | 31,000 | -19.1% | 0.01% | 0.0% |
Q4 2019 | $441,000 | +401.1% | 38,310 | +37.6% | 0.01% | +100.0% |
Q4 2018 | $88,000 | +22.2% | 27,840 | +105.7% | 0.00% | 0.0% |
Q2 2018 | $72,000 | -72.5% | 13,531 | -70.1% | 0.00% | -73.3% |
Q1 2018 | $262,000 | – | 45,245 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BML Capital Management, LLC | 3,915,000 | $5,872,500 | 5.39% |
Versant Venture Management, LLC | 5,068,233 | $7,602,350 | 4.04% |
Sonic GP LLC | 2,000,000 | $3,000,000 | 2.91% |
COMMODORE CAPITAL LP | 10,000,000 | $15,000,000 | 1.75% |
VR Adviser, LLC | 6,573,300 | $9,859,950 | 1.04% |
AIGH Capital Management LLC | 1,323,985 | $1,985,977 | 0.94% |
Newtyn Management, LLC | 1,025,000 | $1,537,500 | 0.38% |
Worth Venture Partners, LLC | 331,668 | $497,502 | 0.30% |
Acuitas Investments, LLC | 291,169 | $436,754 | 0.26% |
Quinn Opportunity Partners LLC | 398,298 | $597,447 | 0.08% |